Inventor
Collette Behrens
Inventor
Macquarie Park, AU
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes36%
C07KPeptides36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
PatentTitleYear
11,117,975Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B202110,544,199Interferon alpha 2B variants202010,232,041Combination of lenalidomide and polypeptide construct, and uses thereof20199,963,515Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B20189,636,334'Combination of lenalidomide and polypeptide construct, and uses thereof'2017Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2017–2021Patents assigned to TEVA PHARMACEUTICALS AUSTRALIA PTY LTD (5)· patent assignee history
2017–2021Based in Macquarie Park, AU· patent location history
2019Patents assigned to TEVA PHARMACEUTICALS PTY LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TEVA PHARMACEUTICALS AUSTRALIA PTY LTD | 5 | 2017–2021 |
| TEVA PHARMACEUTICALS PTY LTD | 1 | 2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| Macquarie Park, AU | 5 | 2017–2021 |